Who owns Valeant Pharmaceuticals Int?

Key details on Valeant Pharmaceuticals Int (Ticker: VRX)

Who owns Valeant Pharmaceuticals Int?

Is VRX a good stock to own? Find out who bought Valeant Pharmaceuticals Int, who sold Valeant Pharmaceuticals Int (VRX) stock, and who holds a large position in Valeant Pharmaceuticals Int.

Fund Name Number of Shares Share Valuation As Of
Ruane, Cunniff & Goldfarb 34.33M $4.91B Dec. 31, 2014
ValueAct Holdings 18.92M $2.48B Sept. 30, 2014
T. Rowe Price Associates 17.84M $2.55B Dec. 31, 2014
Barclays 15.01M $2.15B Dec. 31, 2014
FMR 10.82M $1.42B Sept. 30, 2014
VIKING GLOBAL INVESTORS 9.08M $1.30B Dec. 31, 2014
Lone Pine Capital 8.25M $1.18B Dec. 31, 2014
Blue Ridge Capital Holdings 7.52M $279.13M Sept. 30, 2011
BANK OF MONTREAL /CAN/ 7.18M $1.03B Dec. 31, 2014
JPMORGAN CHASE & CO 6.26M $895.16M Dec. 31, 2014
Greystone Managed Investment 5.83M $311.84M March 31, 2012
Brave Warrior Advisors 5.59M $737.27M March 31, 2014
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 5.52M $790.49M Dec. 31, 2014
Toronto-Dominion Bank 5.48M $718.34M Sept. 30, 2014
Blue Ridge Capital 5.45M $254.46M Dec. 31, 2011
GOLDMAN SACHS 5.34M $764.42M Dec. 31, 2014
Loomis, Sayles and 4.69M $550.74M Dec. 31, 2013
Name Goodman & Company, Investment Counsel 4.62M $207.08M June 30, 2012
Caisse de depot et placement du Quebec 4.57M $599.53M Sept. 30, 2014
Janus Capital Management 4.54M $391.19M June 30, 2013
Brave Warrior Capital 4.41M $236.94M March 31, 2012
CIBC World Markets 4.39M $628.87M Dec. 31, 2014
Brahman Capital 4.36M $241.01M Sept. 30, 2012
MORGAN STANLEY 4.36M $574.15M March 31, 2014
Institutional Capital 4.32M $566.75M Sept. 30, 2014
JANA PARTNERS 4.31M $616.45M Dec. 31, 2014

Who sold Valeant Pharmaceuticals Int?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Sept. 30, 2012 4.86M $255.76M
HARRIS FINANCIAL Sept. 30, 2011 5.69M $211.13M
Royal Bank of Canada Sept. 30, 2011 4.36M $161.66M
Iridian Asset Management June 30, 2011 5.69M $295.60M
Nicholas Investments Partners June 30, 2011 4.40M $4.36M
Commerzbank Aktiengesellschaft Dec. 31, 2010 5.42M $153.32M
Osterweis Capital Management Dec. 31, 2010 4.82M $136.26M